Pfizer-BioNTech omicron-adapted COVID vaccines demonstrate high immune response Ruchika Sharma27 Jun 2022 4:30 PM ISTThe Pfizer-BioNTech COVID-19 Vaccine, which is based on BioNTech's proprietary mRNA technology, was developed by both BioNTech and Pfizer.
Valneva COVID vaccine gets marketing authorization in Europe Ruchika Sharma26 Jun 2022 10:00 AM ISTVLA2001 is the whole virus, inactivated, adjuvanted COVID-19 vaccine.
Fourth dose of Pfizer vaccine protects medicos against COVID-19 hospitalizations and deaths: JAMA Dr. Hiral patel24 Jun 2022 8:00 PM ISTIsrael: In residents of long-term care facilities (LTCFs), the fourth dose of the Pfizer BioNTech (BNT162b2) COVID-19 vaccine was associated with high...
WHO gives nod to Biological E as additional production site for JnJ COVID vaccine Ruchika Sharma23 Jun 2022 4:30 PM ISTIndia's first indigenously developed RBD protein subunit vaccine, Biological E's Corbevax, is currently being used to inoculate children in the age...
Merck Pneumococcal 15-valent Conjugate Vaccine gets USFDA nod for pediatric use Ruchika Sharma23 Jun 2022 12:45 PM ISTRahway: Merck, known as MSD outside the United States and Canada, has announced that the U.S. Food and Drug Administration (USFDA) has approved an...
Merck presents positive results from Pneumococcal conjugate vaccine study Ruchika Sharma22 Jun 2022 2:30 PM ISTPneumococcal disease is an infection caused by the bacterium Streptococcus pneumoniae, or pneumococcus.
Walmart, pharmacy chains plan to vaccinate young children with COVID shots after authorization Ruchika Sharma19 Jun 2022 10:00 AM ISTA spokesperson for Walmart said the retail giant and its unit Sam's Club plan to begin vaccinating children as young as 3.
Union Health Minister says 89% Adults are now fully vaccinated against COVID-19 Medical Dialogues Bureau18 Jun 2022 2:45 PM IST"Congratulations India! With the mantra of 'Sabka Saath and Sabka Prayas', India achieves complete vaccination of over 89 per cent of its adult...
Pfizer, Moderna COVID vaccines get USFDA emergency use nod for kids as young as 6 months MD Bureau18 Jun 2022 12:30 PM ISTThe FDA said its evaluation and analysis of the safety, effectiveness and manufacturing data of these vaccines was rigorous and comprehensive,...
Covaxin demonstrates robust safety and immunogenicity in children 2-18 years, says Bharat Biotech Ruchika Sharma17 Jun 2022 12:46 PM ISTCOVAXIN is a ready to use liquid vaccine, stored at 2-8°C, with 12 months shelf life and multi dose vial policy.
Protection and waning of Natural and Hybrid Immunity to SARS CoV 2 Isra Zaman17 Jun 2022 12:31 PM ISTAmong persons who had been previously infected with SARS-CoV-2, protection against reinfection decreased as the time increased since the last...
CDSCO panel recommends market nod for Serum Institute qHPV vaccine against cervical cancer Ruchika Sharma16 Jun 2022 1:45 PM ISTIn the application, Singh is learnt to have stated that qHPV vaccine CERVAVAC has demonstrated robust antibody response that is nearly 1,000 times...
